Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-28

Clinical Trial Update: Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy [NA]

View source ↗

Summary

A clinical trial evaluating pregabalin for idiopathic small fiber neuropathy has been terminated. The study sponsor is the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: University of Alberta | Conditions: Small-Fiber Neuropathy | NA | Status: TERMINATED